Use access key #2 to skip to page content.

inthemoneystock (< 20)

The One True Sector Bubble: Profits Here When It Crashes Soon



December 10, 2013 – Comments (1) | RELATED TICKERS: CELG , GILD

There has been constant talk about the overall market being in a bubble. Is it a bubble? To some extent yes, however there is one particular sector that is in the stratosphere. The biotechnology sector is the equivalent of the sector in 1999. To see the type of moves I am talking about, take a quick look at Celgene Corporation (NASDAQ:CELG) and Gilead Sciences, Inc. (NASDAQ:GILD). Both stocks are up more than 100% in 2013 with market caps exceeding mega cap stature.

If you believe the market will pull back in 2014, which I believe. The biotech sector could see the biggest fall from these bubble levels. Imagine even a 50% retrace of the 2013 moves. Major profits to be had. If interested, you can short the iShares NASDAQ Biotechnology Index (NASDAQ:IBB) or buy the ProShares UltraShort Nasdaq Biotech ETF (NYSEARCA:BIS). Both give you plenty of exposure to the collapse in the biotech sector.

Gareth Soloway


1 Comments – Post Your Own

#1) On December 10, 2013 at 9:09 PM, jiltin (47.31) wrote:

You are talking about 100% growth in a year for both the companies. These two companies are poor when you compare SCTY and SPWR as they are around 500% up over the last year.

SCTY NP Margin is same in 2012 and 2013, but 500% share value increased.

Net profit margin-71.18%-71.17%

Do you think SCTY and SPWR sector or poor CELG and GILD sector?

Report this comment

Featured Broker Partners